{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:06:31Z","timestamp":1790309191880,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"DOI":"10.1186\/s12874-024-02395-z","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T23:38:55Z","timestamp":1731627535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A study within a trial (SWAT) of clinical trial feasibility and barriers to recruitment in the United Kingdom \u2013 the CapaCiTY programme experience"],"prefix":"10.1186","volume":"24","author":[{"given":"Natasha","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Emmett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybil","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yiannakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the CapaCiTY programme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"2395_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jclinepi.2016.05.005","volume":"77","author":"N Stevens","year":"2016","unstructured":"Stevens N, et al. Risk based survey evidence supports electronic informed consent as a recruitment method for UK clinical trials. J Clin Epidemiol. 2016;77:134\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2395_CR2","doi-asserted-by":"publisher","first-page":"e000496","DOI":"10.1136\/bmjopen-2011-000496","volume":"2","author":"B Fletcher","year":"2012","unstructured":"Fletcher B, et al. Improving the recruitment activity of clinicians in randomised controlled trials: a systematic review. BMJ Open. 2012;2(1):e000496.","journal-title":"BMJ Open."},{"key":"2395_CR3","unstructured":"Research, N.I.H. Value of Awards. Available from: https:\/\/nihr.opendatasoft.com\/pages\/nihr-awards-filters\/-value-of-awards#-value-of-awards."},{"issue":"3","key":"2395_CR4","doi-asserted-by":"publisher","first-page":"e015276","DOI":"10.1136\/bmjopen-2016-015276","volume":"7","author":"SJ Walters","year":"2017","unstructured":"Walters SJ, et al. Recruitment and retention of participants in randomised controlled trials: a review of trials funded and published by the United Kingdom Health Technology Assessment Programme. BMJ Open. 2017;7(3):e015276.","journal-title":"BMJ Open."},{"key":"2395_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1745-6215-7-9","volume":"7","author":"AM McDonald","year":"2006","unstructured":"McDonald AM, et al. What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials. 2006;7:9.","journal-title":"Trials."},{"key":"2395_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4155\/cli.14.139","volume":"5","author":"O Johnson","year":"2015","unstructured":"Johnson O. An evidence-based approach to conducting clinical trial feasibility assessments. Clin Invest. 2015;5:491\u20139.","journal-title":"Clin Invest"},{"key":"2395_CR7","doi-asserted-by":"publisher","first-page":"100900","DOI":"10.1016\/j.conctc.2022.100900","volume":"26","author":"V Bogin","year":"2022","unstructured":"Bogin V. Lasagna\u2019s law: a dish best served early. Contemp Clin Trials Commun. 2022;26:100900.","journal-title":"Contemp Clin Trials Commun."},{"issue":"3","key":"2395_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/2229-3485.71867","volume":"1","author":"V Rajadhyaksha","year":"2010","unstructured":"Rajadhyaksha V. Conducting feasibilities in clinical trials: an investment to ensure a good study. Perspect Clin Res. 2010;1(3):106\u20139.","journal-title":"Perspect Clin Res"},{"key":"2395_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018;11:156\u201364.","journal-title":"Contemp Clin Trials Commun"},{"issue":"1","key":"2395_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1745-6215-15-32","volume":"15","author":"C Tudur Smith","year":"2014","unstructured":"Tudur Smith C, et al. The trials methodological research agenda: results from a priority setting exercise. Trials. 2014;15(1):32.","journal-title":"Trials."},{"issue":"2","key":"2395_CR11","first-page":"p. Mr000013","volume":"2","author":"S Treweek","year":"2018","unstructured":"Treweek S, et al. Strategies to improve recruitment to randomised trials. Cochrane Database Syst Rev. 2018;2(2):Mr000013.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2395_CR12","first-page":"p. Mr000045","volume":"10","author":"C Houghton","year":"2020","unstructured":"Houghton C, et al. Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2020;10(10):Mr000045.","journal-title":"Cochrane Database Syst Rev"},{"key":"2395_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fpain.2023.1330937","volume":"4","author":"JK Anastasi","year":"2024","unstructured":"Anastasi JK, et al. Recruitment and retention of clinical trial participants: understanding motivations of patients with chronic pain and other populations. Frontiers in Pain Research. 2024;4:4.","journal-title":"Frontiers in Pain Research"},{"issue":"16_suppl","key":"2395_CR14","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1200\/JCO.2024.42.16_suppl.1619","volume":"42","author":"AIV Manana","year":"2024","unstructured":"Manana AIV, et al. Challenges and solutions to recruiting diverse populations to oncology clinical trials: a mixed-methods study of clinical research coordinators. Journal of Clinical Oncology. 2024;42(16_suppl):1619\u20131619.","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"2395_CR15","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1186\/s13063-021-05818-0","volume":"22","author":"M Briel","year":"2021","unstructured":"Briel M, et al. Exploring reasons for recruitment failure in clinical trials: a qualitative study with clinical trial stakeholders in Switzerland, Germany, and Canada. Trials. 2021;22(1):844.","journal-title":"Trials"},{"key":"2395_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.12688\/hrbopenres.13776.2","volume":"6","author":"L Muldowney","year":"2024","unstructured":"Muldowney L, et al. A qualitative exploration of advantages and disadvantages to using technology in the process of randomised controlled trial recruitment [version 2; peer review: 1 approved, 1 approved with reservations]. HRB Open Res. 2024;6:56.","journal-title":"HRB Open Res"},{"key":"2395_CR17","doi-asserted-by":"publisher","first-page":"101245","DOI":"10.1016\/j.conctc.2023.101245","volume":"37","author":"VK Ortner","year":"2024","unstructured":"Ortner VK, et al. Accelerating patient recruitment using social media: early adopter experience from a good clinical practice-monitored randomized controlled phase I\/IIa clinical trial on actinic keratosis. Contemp Clin Trials Commun. 2024;37:101245.","journal-title":"Contemp Clin Trials Commun."},{"issue":"2","key":"2395_CR18","first-page":"1","volume":"28","author":"A Parker","year":"2024","unstructured":"Parker A, et al. Undertaking studies within a trial to evaluate recruitment and retention strategies for RCTs: lessons learnt from the PROMETHEUS research programme. Health Serv Deliv Res. 2024;28(2):1\u2013114.","journal-title":"Health Serv Deliv Res"},{"issue":"10","key":"2395_CR19","doi-asserted-by":"publisher","first-page":"e045233","DOI":"10.1136\/bmjopen-2020-045233","volume":"11","author":"N Farrar","year":"2021","unstructured":"Farrar N, et al. Recruiters\u2019 perspectives and experiences of trial recruitment processes: a qualitative evidence synthesis protocol. BMJ Open. 2021;11(10):e045233.","journal-title":"BMJ Open"},{"key":"2395_CR20","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.conctc.2021.100829","volume":"23","author":"E Rodr\u00edguez-Torres","year":"2021","unstructured":"Rodr\u00edguez-Torres E, Gonz\u00e1lez-P\u00e9rez MM, D\u00edaz-P\u00e9rez C. Barriers and facilitators to the participation of subjects in clinical trials: an overview of reviews. Contemp Clin Trials Commun. 2021;23:100829.","journal-title":"Contemp Clin Trials Commun"},{"key":"2395_CR21","unstructured":"Collaboration, U.C.R. Registered Clinical Trials Units. Available from: https:\/\/www.ukcrc.org\/research-infrastructure\/clinical-trials-units\/registered-clinical-trials-units\/."},{"key":"2395_CR22","unstructured":"Confederation N. What are clinical commissioning groups. Available from: https:\/\/www.nhsconfed.org\/articles\/what-are-clinical-commissioning-groups."},{"key":"2395_CR23","unstructured":"Knowles, C.H., et al., Programme grants for applied research, in Non-drug therapies for the management of chronic constipation in adults: the CapaCiTY research programme including three RCTs. 2021, NIHR J Library Copyright \u00a9 2021 Knowles et al. This work was produced by Knowles et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaption in any medium and for any purpose provided that it is properly attributed. See: https:\/\/creativecommons.org\/licenses\/by\/4.0\/. For attribution the title, original author(s), the publication source \u2013 NIHR Journals Library, and the DOI of the publication must be cited.: Southampton (UK)."},{"issue":"1","key":"2395_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13063-017-1880-0","volume":"18","author":"C Norton","year":"2017","unstructured":"Norton C, et al. Habit training versus habit training with direct visual biofeedback in adults with chronic constipation: study protocol for a randomised controlled trial. Trials. 2017;18(1):139.","journal-title":"Trials"},{"issue":"11","key":"2395_CR25","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1111\/codi.16738","volume":"25","author":"C Norton","year":"2023","unstructured":"Norton C, et al. Habit training versus habit training with direct visual biofeedback in adults with chronic constipation: A randomized controlled trial. Colorectal Dis. 2023;25(11):2243\u201356.","journal-title":"Colorectal Dis"},{"issue":"1","key":"2395_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13063-017-1882-y","volume":"18","author":"C Emmett","year":"2017","unstructured":"Emmett C, et al. Low-volume versus high-volume initiated trans-anal irrigation therapy in adults with chronic constipation: study protocol for a randomised controlled trial. Trials. 2017;18(1):151.","journal-title":"Trials"},{"issue":"1","key":"2395_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13063-018-2456-3","volume":"19","author":"U Grossi","year":"2018","unstructured":"Grossi U, et al. Stepped-wedge randomised trial of laparoscopic ventral mesh rectopexy in adults with chronic constipation: study protocol for a randomized controlled trial. Trials. 2018;19(1):90.","journal-title":"Trials"},{"issue":"12","key":"2395_CR28","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s10151-022-02633-w","volume":"26","author":"U Grossi","year":"2022","unstructured":"Grossi U, et al. Stepped-wedge randomized controlled trial of laparoscopic ventral mesh rectopexy in adults with chronic constipation. Tech Coloproctol. 2022;26(12):941\u201352.","journal-title":"Tech Coloproctol"},{"key":"2395_CR29","unstructured":"York, U.o. Trial Forge Studies Within A Trial (SWAT); Available from: https:\/\/www.york.ac.uk\/healthsciences\/research\/trials\/swats\/. Cited 2023 13 January."},{"key":"2395_CR30","doi-asserted-by":"publisher","first-page":"m3099","DOI":"10.1136\/bmj.m3099","volume":"370","author":"H Haskell","year":"2020","unstructured":"Haskell H. Cumberlege review exposes stubborn and dangerous flaws in healthcare. BMJ. 2020;370:m3099.","journal-title":"BMJ."},{"key":"2395_CR31","unstructured":"Review, T.I.M.a.M.D.S., First Do No Harm. 2020."},{"key":"2395_CR32","unstructured":"Risks, E.C.S.C.o.E.a.N.I.H. Opinion on the safety of surgical meshes used in urogynecological surgery. 2015; Available from: https:\/\/health.ec.europa.eu\/scientific-committees_en."}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-024-02395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-024-02395-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-024-02395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:06:22Z","timestamp":1731629182000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-024-02395-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2395"],"URL":"https:\/\/doi.org\/10.1186\/s12874-024-02395-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3406175\/v1","asserted-by":"object"}]},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study within a trial (SWAT) was approved by the Queen Mary University of London Ethics Committee, QMREC2023a. The overarching clinical trials were approved by London City and East Human Research Ethics Committee; CapaCiTY01\u00a0REC 14\/LO\/1786 ISRCTN11791740, CapaCiTY02: REC 15\/LO\/0732, ISRCTN11093872, CapaCiTY03: REC 15\/LO\/0732, ISRCTN11747152. Informed consent was provided by all participants in accordance with the ethics approvals. All methods were carried out according to the clinical trial regulations, local governance requirements and quality assurance procedures including; The Medicines for Human Use (Clinical Trials) Regulations 2004, Good Clinical Practice, Data Protection Act, NHS Caldicott Principles, The UK Research Governance Framework for Health and Social Care, Pragmatic Clinical Trials Unit Standard Operating Procedures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}